yeast two-hybrid screen

French biotech firm Hybrigenics said this week that it has renewed a three-year, $2.4 million research services agreement with an unnamed US life sciences company.

Medical University of Vienna researchers have developed a protein-proximity assay for investigating and validating short-lived protein-protein interactions.

This story originally ran on Feb. 1.
French biotech firm Hybrigenics this week reported €6.6 million ($8.7 million) in revenues for 2011, up 45 percent from €4.5 million in 2010.

By Adam Bonislawski

This story originally ran on Oct. 18
French biotech company Hybrigenics this week reported €1.85 million ($2.52 million) in first-half revenues from its proteomics services business, up eight percent from €1.71 million in the first half of 2010.

Using a yeast two-hybrid-based system, researchers from the Arabidopsis Interactome Mapping Consortium mapped roughly 6,200 reliable interactions between about 2,700 proteins and identified a small subset of proteins likely key to plant pathogen response.

The research could prove useful in classifying autism patients according to functional pathways and protein interactions, ultimately enabling more effective development and targeting of therapies for the disorder.